G

Galderma Group AG
SIX:GALD

Watchlist Manager
Galderma Group AG
SIX:GALD
Watchlist
Price: 112.5 CHF 0.63% Market Closed
Market Cap: 26.7B CHF
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+2%
Revenue
Forecast
+14%
Operating Income
Forecast
+34%
Net Income
Forecast
+75%

Wall Street
Price Targets

GALD Price Targets Summary
Galderma Group AG

Wall Street analysts forecast GALD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GALD is 114.2 CHF with a low forecast of 106.05 CHF and a high forecast of 134.4 CHF.

GALD Lowest Forecast
Wall Street Target
106.05 CHF
6% Downside
GALD Average Forecast
Wall Street Target
114.2 CHF
2% Upside
GALD Highest Forecast
Wall Street Target
134.4 CHF
19% Upside
Lowest
Price Target
106.05 CHF
6% Downside
Average
Price Target
114.2 CHF
2% Upside
Highest
Price Target
134.4 CHF
19% Upside
Galderma Group AG Competitors:
Price Targets
603727
BOMESC Offshore Engineering Co Ltd
32% Upside
PSI
Pason Systems Inc
28% Upside
P
PVC
Petrovietnam Chemical and Services Corp
80% Upside
S
MDAI
Spectral AI Inc
184% Upside
603727
BOMESC Offshore Engineering Co Ltd
32% Upside
PSI
Pason Systems Inc
28% Upside
P
PVC
Petrovietnam Chemical and Services Corp
80% Upside
S
MDAI
Spectral AI Inc
184% Upside
R
RSGN
R&S Group Holding AG
1% Upside
365550
ESR Kendall Square REIT Co Ltd
44% Upside

Revenue
Forecast

Revenue Estimate
Galderma Group AG

For the last 2 years the compound annual growth rate for Galderma Group AG's revenue is 8%. The projected CAGR for the next 3 years is 14%.

8%
Past Growth
14%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Galderma Group AG

For the last 2 years the compound annual growth rate for Galderma Group AG's operating income is 30%. The projected CAGR for the next 3 years is 34%.

30%
Past Growth
34%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Galderma Group AG

The compound annual growth rate of Galderma Group AG's net income for the next 3 years is 75%.

N/A
Past Growth
75%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
GALD intrinsic value, competitors valuation, and company profile.
DCF Valuation
GALD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GALD stock valuation using valuation multiples.
Wall Street Estimates
GALD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GALD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GALD's stock price target?
Price Target
114.2 CHF

According to Wall Street analysts, the average 1-year price target for GALD is 114.2 CHF with a low forecast of 106.05 CHF and a high forecast of 134.4 CHF.

What is Galderma Group AG's Revenue forecast?
Projected CAGR
14%

For the last 2 years the compound annual growth rate for Galderma Group AG's revenue is 8%. The projected CAGR for the next 3 years is 14%.

What is Galderma Group AG's Operating Income forecast?
Projected CAGR
34%

For the last 2 years the compound annual growth rate for Galderma Group AG's operating income is 30%. The projected CAGR for the next 3 years is 34%.

What is Galderma Group AG's Net Income forecast?
Projected CAGR
75%

The compound annual growth rate of Galderma Group AG's net income for the next 3 years is 75%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.